Red Ear Syndrome: A Case Report and Review of Literature Authors: Zaki Alwatban, Wasan Alharbi, Muneera Al Khalifa, Mohammed Al Shehabi Published: 2026 ABSTRACT Red ear syndrome (RES) is a rare disorder characterized by episodic erythema, warmth, and burning pain of the external ear. RES is frequently associated with migraine. We report the case of a 35‐year‐old male with a long‐standing history of poorly controlled migraine who presented with recurrent bilateral auricular erythema and burning pain, predominantly affecting the left ear. Symptoms were triggered by migraine attacks, heat exposure, and ear manipulation and relieved by cooling measures. Clinical examination, laboratory investigations, and imaging were normal. RES was diagnosed after excluding infectious and inflammatory causes. Treatment with indomethacin and magnesium resulted in complete symptom resolution. RES should be considered in patients with recurrent auricular erythema and burning pain, particularly in those with migraine. Careful clinical assessment and systematic exclusion of alternative diagnoses are crucial for identifying RES and preventing inappropriate management. 1. Introduction Red ear syndrome (RES), also known as auricular erythermalgia, is a rare clinical condition first described by Lance in 1994 and further characterized in 1996 [1–4]. RES is defined by paroxysmal episodes of unilateral or bilateral erythema of the external ear, accompanied by warmth and burning pain [1]. These episodes are typically precipitated by mechanical or physiological stimuli, including touching or rubbing the ear, heat exposure, migraine attacks, neck movement, chewing or jaw motion, physical exertion, and emotional stress [4, 5]. The true incidence and prevalence of RES remain unknown, largely owing to the limited number of reported cases; thus, the condition is regarded as rare [4]. The pathophysiology of RES is not fully understood; however, it is generally classified into primary (central) and secondary (peripheral) diseases [6], with some cases demonstrating overlapping features of both mechanisms [7]. Primary RES is typically idiopathic or associated with migraine and trigeminal autonomic cephalalgias (TACs) [5]. In contrast, secondary RES has been associated with upper cervical spine pathology and temporomandibular joint (TMJ) dysfunction [5]. In this study, we present a case of RES in a patient with migraine, accompanied by a comprehensive review of current literature, with particular emphasis on clinical features, proposed pathophysiological mechanisms, differential diagnosis, and management strategies. 2. Case Presentation A 35‐year‐old male with a long‐standing history of poorly controlled migraine since childhood presented to the otorhinolaryngology clinic with recurrent episodes of bilateral ear redness associated with pain. The patient had previously attended multiple clinics and had been repeatedly treated for otitis externa without clinical improvement. At presentation, he described episodic redness of both ears, predominantly involving the left ear, accompanied by sensations of warmth, burning, and throbbing pain. Similar but milder symptoms were occasionally noted in the right ear. These episodes were temporally associated with unilateral left temporal headaches consistent with his known migraine and were accompanied by visual aura. Symptoms were intermittent, self‐limiting, and recurrent. Exacerbating factors included migraine attacks, exposure to hot weather, and ear rubbing, whereas symptom relief was achieved with cooling measures and improvement in headache. The patient denied hearing loss, tinnitus, otorrhea, TMJ dysfunction, dental problems, neck pain, rheumatologic or joint symptoms, and nasal or allergic complaints. The patient reported a positive family history of migraine in his father. On physical examination, bilateral erythema of the auricles with increased warmth was observed, without tenderness or fluctuation (Figure 1). Otoscopic examination revealed normal external auditory canals and intact tympanic membranes bilaterally. The remainder of the otorhinolaryngologic examination, including head and neck assessment and TMJ evaluation, was unremarkable (Figure 2). Clinical and otoscopic findings of the patient with red ear syndrome. (a) Left auricle showing erythema and redness. (b) Right auricle showing erythema and redness. (c) Normal otoscopic examination of the left ear. (d) Normal otoscopic examination of the right ear. CT scan of the TMJ (multiple views). (a) Coronal CT scan of the TMJ showing a normal TMJ. (b) Axial CT scan of the TMJ showing a normal TMJ. (c) Sagittal CT scan of the right TMJ showing a normal TMJ. (d) Sagittal CT scan of the left TMJ showing a normal TMJ. TMJ, temporomandibular joint; CT, computed tomography. Laboratory investigations, including routine blood tests and a rheumatologic workup for systemic lupus erythematosus, Sjögren’s syndrome, and relapsing polychondritis, were within normal limits. Computed tomography of the TMJs showed no abnormalities. After excluding alternative diagnoses such as otitis externa, erysipelas, eczematous dermatologic conditions, and relapsing polychondritis, a diagnosis of RES was established. The patient was treated with indomethacin (25 mg once daily for 3 weeks) and magnesium supplementation (600 mg once daily) and was advised to avoid known triggering factors. He reported marked clinical improvement at 1‐month follow‐up, with complete resolution of ear redness, warmth, and burning sensations (Figure 3). No adverse or unanticipated events were reported. Clinical examination of ear after medical management. (a) Left auricle shows resolution of erythema and redness after medical management. (b) Right auricle shows resolution of erythema and redness after medical management. 3. Discussion RES is a rare clinical entity characterized by recurrent episodes of unilateral or bilateral erythema, warmth, and burning pain of the external ear [1]. Despite increasing recognition in the literature, its underlying pathophysiology remains poorly understood [8]. Several mechanisms have been proposed and can be broadly categorized into central and peripheral mechanisms [7]. Central mechanisms primarily involve dysfunction of the brainstem trigeminoautonomic network. Goadsby and Lipton proposed the trigeminoautonomic circuit dysregulation theory, suggesting impaired regulation between trigeminal nerve activation and facial parasympathetic outflow. According to this hypothesis, stimulation of the trigeminal nerve by various triggers leads to abnormal parasympathetic responses, resulting in vasodilation and pain [4, 7, 9]. In addition, Raielli et al. proposed that activation of the trigeminovascular system leads to the release of vasoactive substances, resulting in vasodilation, erythema, and pain [4, 7, 10]. These central mechanisms are supported by the strong association between RES and headache disorders, particularly migraine. Furthermore, peripheral mechanisms have been implicated, particularly in secondary forms of RES. Lance et al. suggested that antidromic discharge from the upper cervical nerve roots (C2‐C3), often related to cervical spine pathology, leads to the release of vasodilatory neuropeptides, resulting in auricular erythema and pain. TMJ dysfunction has also been proposed as a peripheral trigger. In this model, non‐noxious stimuli such as heat, touch, or chewing activate a local axon reflex, causing antidromic nerve discharges that result in neurogenic inflammation, vasodilation, and pain [3, 4, 7]. The diagnosis of RES remains primarily a diagnosis of exclusion. A broad differential diagnosis must be considered, including otitis externa, erysipelas, eczematous dermatologic conditions, relapsing polychondritis which preserve ear lobule, and other inflammatory or infectious causes of auricular erythema and pain [11, 12]. A comprehensive ENT examination is essential, supported by basic and targeted laboratory investigations. Evaluation for cervical spine and TMJ pathology is mandatory in suspected cases of secondary RES. Magnetic resonance imaging (MRI) of the brain and TMJ should be considered in patients with high clinical suspicion or associated neurological symptoms [5]. Our literature review of 45 articles comprising 100 reported cases of RES (Tables 1 and 2) indicated that the condition predominantly affected females (63%), with a mean age of 36.6 years. The left ear was most commonly involved (36%), followed by bilateral involvement (24%). Primary RES was the most frequent subtype (58%), followed by secondary and mixed forms (21% each). Headache disorders were present in 62% of the cases, with migraine accounting for 44%, further supporting the involvement of trigeminoautonomic and trigeminovascular mechanisms. Identifiable triggering factors were reported in 73% of the cases, reinforcing the contribution of both central and peripheral stimuli. TABLE 1Literature review of demographic data, clinic presentation, and characteristics of RES.VariableFrequency (n)Percentages (%)Sex Male3737 Female6363Mean age36.6 Y Max age92 Y Min age1.5 Y Affected ear Right ear2121 Left ear3636 Bilateral ear2424 Not mentioned1919History of headache Yes1818 Yes‐Migraine4444 No3838Secondary cause Yes4242 No5858Triggering factors Yes7373 No trigger1313 Not mentioned1414Relieving factors Yes2222 No11 Not mentioned7777Types Idiopathic5858 Secondary2121 Mixed2121Abbreviation: RES, red ear syndrome. Literature review of demographic data, clinic presentation, and characteristics of RES. Abbreviation: RES, red ear syndrome. TABLE 2Literature review of case numbers, demographic data, clinic presentation, and characteristics of RES.SNYearAuthorCNAgeSexPresentation of RESEar(s)HeadacheSecondary causeTriggersRelieving factorManagement11996Lance [3]12 183MRight ear pain (burning sensation) and rednessRNCervical arachnoiditisTouching the earNMMethysergide 273FLeft ear pain and warmthLNCervical spondylosisCoughing, sneezing, or flexing her neck while turning to the leftNMIndomethacin 362MLeft ear pain, redness, and warmthLYCervical spondylosisNMNMNM 437MLeft ear pain (burning sensation), redness, and warmthLNCervical spondylosisExertionCold pack or had a cold showerPropranolol and C2‐C3 block 533FRight ear pain (burning sensation) and rednessRNTraction injury of upper cervical rootsNeck movement and stressNMNM 650FLeft ear pain, redness, and swellingLY‐MAtypical glossopharyngeal and third cervical root neuralgiaTouchNMFlunarizine, C3 root block and C3 section 735MLeft ear pain and rednessLNAtypical glossopharyngeal and third cervical root neuralgiaOpening mouth, drinking or ear exposure to coldNMSurgical section of left glossopharyngeal nerve 812MBilateral ear pain and rednessB/LNTMJ dysfunctionChewing or tooth grindingNMDental plate 942FLeft ear pain (burning sensation) and rednessLY‐MAtypical trigeminal neuralgia: DysfunctionMenstrual period or any emotional stressNMAmitriptyline 1042FLeft ear pain and rednessLY‐MThalamic syndrome with secondary migraines symptomsNMNMImipramine 1144FRight ear pain and rednessRY—heatIce pack to the earSupportive measures 1214FRight ear pain (burning sensation) and rednessRY—Touch, heat, hair brushing or chewingNMNo treatment 21998Dodick [13]159FLeft ear pain and rednessLYExtra trigeminal EPHHeadacheNMIndomethacin 31998Boes et al. [14]2 142FLeft ear pain and rednessLYCPHNTNMIndomethacin 249FRight ear painRYCPHNTNMIndomethacin 42000Lee et al. [15]19MBilateral ear pain (burning sensation), redness, and swellingB/LYNeuropsychiatric SLE, vasculitic lesion of left MCANTNMDiazepam and methylprednisolone 52002Raieli et al. [10]8 110MBilateral ear pain (burning sensation) and rednessB/LY‐M—NTIce pack to the earNimodipine 28MEar pain and rednessNMY‐M—NTNMNM 39MLeft ear pain (burning sensation) and rednessLY‐M—Migraine attackNMNM 412FLeft ear pain (burning sensation) and rednessLY‐M—Migraine attackNMNM 55MBilateral ear pain (burning sensation) and rednessB/LY‐M—Migraine attackNMNM 613MRight ear pain (burning sensation) and rednessRY‐M—Stress or migraine attackNMNM 711MRight ear pain (burning sensation) and rednessRY‐M—Migraine attackNMFlunarizine 836FLeft ear pain (burning sensation) and rednessLY‐M—Migraine attackNMNM 62004Donnet and Valade [16]2 122MBilateral ear pain (burning sensation) and rednessB/LY‐MTACMigraine attackNMNM 292FLeft ear pain (burning sensation) and rednessLNTACNTNMNM 72004Kumar and Swanson [17]2 166MLeft ear pain (burning sensation), redness, and warmthLNCervical root neuralgia (degenerative changes at C4 and C5 interspace with narrowing of the left C4 neural foramen)TouchNMNM 266MRight ear pain (burning sensation) and warmthRNCervical root neuralgia (spur at the C4 interspace on the right with narrowing of C4 neural foramen)Head movementNMNM 82004Ramirez and Kirsner [18]153MBilateral ear pain (burning sensation) and rednessB/LNPrimary erythromelalgiaHeat or physical activityCoolingMultiple medication with no effect 92004Evans and Lance [19]154FLeft ear pain (burning sensation) and rednessLY‐M—NMNMNM 102005Al‐Din et al. [20]18 142FEar pain, redness, and hotnessNMN—Change temperatureNMGabapentin 258FEar pain, redness, and hotnessNMNTMJ dysfunctionLaying down or TMJ touchNMGabapentin 351FEar pain, redness, and hotnessNMY‐M—Change temperatureNMGabapentin 439FEar pain, redness, and hotnessNMNTMJ dysfunctionLaying down or TMJ touchNMGabapentin 549FEar pain, redness, and hotnessNMY‐M—Change temperatureNMGabapentin 645FEar pain, redness, and hotnessNMY‐MTMJ dysfunctionLaying down or TMJ touchNMGabapentin 737FEar pain, redness, and hotnessNMNPleomorphic adenoma of carotid body (ipsilateral) + TMJ dysfunctionLaying down or TMJ touchNMGabapentin 876FEar pain, redness, and hotnessNMNTMJ dysfunctionLaying down or TMJ touchNMGabapentin 954FEar pain, redness, and hotnessRY‐M—Change temperature or migraine attackNMGabapentin 1057FEar pain, redness, and hotnessNMNTMJ dysfunctionLaying down or TMJ touchNMIndomethacin 1129FEar pain, redness, and hotnessLY‐M—Change temperature or migraine attackNMGabapentin 1260MEar pain, redness, and hotnessNMN—Change temperatureNMGabapentin 1362FEar pain, redness, and hotnessNMY‐M—NMNMNSAID 1436FEar pain, redness, and hotnessNMNTACNMNMGabapentin 1556FEar pain, redness, and hotnessNMY‐M—NMNMVerapamil and gabapentin 1625FEar pain, redness, and hotnessNMNTMJ dysfunctionNMNMVerapamil 1750FEar pain, redness, and hotnessNMN—NMNMGabapentin 1825FEar pain, redness, and hotnessNMY‐MTMJ dysfunctionNMNMGabapentin 112005Arjona et al. [21]5 170FEar pain and rednessLYHerpes zosterHerpes zosterNMFamciclovir, prednisone and amitriptyline 223FEar pain and rednessRY—NMNMAmitriptyline 341MEar pain and rednessLYChiari I malformationSexual intercourseNMAmitriptyline and indomethacin 426FEar pain and rednessRY‐M—NMNMAmitriptyline and piroxicam 548FEar pain and rednessLNTMJ dysfunctionNMNMAmitriptyline 122007Boulton et al. [22]3 149FLeft ear pain and rednessLY‐MTMJ dysfunction, idiopathic congenital fusion of C1–C3 and enlargement of the cervical spinal canalcoldCompression of earGabapentin and ibuprofen 266FLeft ear pain and rednessLN——Head movementsIbuprofen 358FLeft ear pain and rednessLY‐MTMJ dysfunctionHeat or touchNMIndomethacin 132009Brill et al. [23]17MBilateral ear pain (burning sensation), redness, and swellingB/LY—heatcoolingMultiple medication with no effect 142009Selekler et al. [24]19MBilateral ear pain (burning sensation) and rednessB/LN—TouchNMGreat auricular nerve block 152010Creach et al. [25]144FRight ear pain and rednessRYC3 root and vertebral artery compressionHead movement or hard physical activityNMNeurovascular decompression of right vertebral artery 162011Eismann et al. [12]131FRight ear pain (burning sensation), redness, and swellingRY‐M—Emotional stress, rubbing of the ear lobe or heatcoolingTopical steroid 172012Anesi et al. [26]156FBilateral ear pain, redness, and swellingB/LN—Ara‐C (anticancer drug)NMNo intervention 182012Ryan et al. [8]123FLeft ear pain (burning sensation), rednessLN—NTNMMultiple medication with no effect 192013Picco et al. [27]110MLeft ear pain (burning sensation) and rednessLY‐MCochleovestibular symptomatologyHeatNMCarbamazepine 202013Lambru et al. [6]169FRight ear pain (burning sensation) and rednessRYSUNCTWind, touch, cleaning her teeth, eating, drinking, or brushing her hairNMLamotrigine 212014Lai et al. [28]139MLeft ear pain (burning sensation) and rednessB/LNTMJ dysfunctionTMJ movement or touchNMNSAID 222014Chen et al. [11]118FBilateral ear pain (burning sensation), redness, and warmthB/LN—Warmth and movement, cleaning her teeth, eating, drinking, brushing her hair, touching, rubbing the ears or neck movementsCold environmentAspirin 232014Chan and Ghosh [29]122FRight ear pain (burning sensation), rednessRY‐M—Stress or orange juiceAvoidance of triggerSupportive management 242014Moitri et al. [30]15MBilateral ear pain (burning sensation), redness, and swellingB/LN—NTNMCetirizine 252014Uca and Kozak [31]111MRight ear pain (burning sensation) and rednessRY‐M—Migraine attackNMAmitriptyline 262014Flicinski et al. [32]111FLeft ear pain (burning sensation), redness, and swellingLY‐M—Heat—Carbamazepine with no effect 272015Lisotto et al. [33]128FLeft ear pain (burning sensation), rednessLN—NMNMPregabalin 282016Velasco et al. [34]126FRight ear pain (burning sensation) and rednessRY‐M—Migraine attackIce pack to the ear.Topiramate 292016Kalladka et al. [35]141MLeft ear pain (burning sensation) and redness and swellingLY‐M—Migraine attack, hot temperature, or sun exposureNMGabapentin 302017Coleman and Ream [36]110MBilateral ear pain (burning sensation), redness, and swellingB/LY‐M—Touch, heat or stressCoolingVerapamil 312017Chan et al. [37]135MBilateral ear pain (burning sensation) and rednessB/LY—Hot temperature or alcohol intakeNMIndomethacin 322018Sahu et al. [38]136FBilateral ear erythemaB/LN—Ara‐C (anticancer drug)Stop the medicationStop the medication 332018La Mantia and Andaloro [39]14MLeft ear pain (burning sensation) and rednessLY‐M—Migraine attackNMCetirizine 342018de Amorim et al. [40]6 122FLeft ear pain, redness, and swellingLY‐M—NTNMSumatriptan, indomethacin, and oxygen 282FLeft ear pain and rednessLY—NTNMSteroids and onabotulinum toxin A 338FLeft ear pain and rednessLY‐M—stressNMNaproxen 444MRight ear pain and rednessRY‐M—NTNMMultiple medication with no effect 545FRight ear pain and rednessRY‐M—NTNMMultiple medication with no effect 667FLeft ear pain and rednessLY‐MBilateral reduction of the C3‐C4 foraminal amplitudeNTNMAmitriptyline with no effect 352019Waseem et al. [41]160FBilateral ear erythemaB/LN—Ara‐C(anticancer drug)NMPrednisone and oral diphenhydramine 362019Cinats and Haber [42]111MBilateral ear pain (burning sensation), redness, and swellingB/LY—Laying down on ears, tactile stimulation or stressIce pack to the earGabapentin 372020Brackenrich et al. [43]157MBilateral ear pain (burning sensation), redness, and swellingB/LNDegenerative changes C4‐5Sun or heatCoolingParoxetine and aspirin 382020Patel et al. [7]3 123FLeft ear pain and rednessLN—Sunlight, wearing hairband, combing hair, lack of sleep, or travel postlunchIce pack to the ear and restAmitriptyline 221MLeft ear pain and rednessLY—Missing breakfast, sun, or travelingParacetamol and sleepFlunarizine 326FBilateral ear pain (burning sensation) and rednessB/LN—Eating sour food, strong perfume, getting emotional, or speaking a lieParacetamol and restNo treatment 392020Soares et al. [44]157FLeft ear pain (burning sensation) and rednessLY‐MTympanoplastyHot water or airNMDuloxetine 402021D’Amico et al. [45]3 111MBilateral ears pain (burning sensation) and rednessB/LY‐M—Migraine attackNMLevosulpiride and valproic acid 28FBilateral ear pain and rednessB/LN—StressIce pack to the ear.Magnesium supplement 31.5MRight ear pain and rednessRYTACNMNMNo treatment 412022Ye et al. [1]112MBilateral ear pain (burning sensation), redness, and warmthB/LNCervical spondylopathyWarmth, movement, stress, excitement, or climbing stairsCold water, staying in cold room, and sitting up at night hoursSystemic itraconazole 422022Sigdel and Pokhrel [46]114MBilateral ear pain (burning sensation) and rednessB/LN—Summer seasonNo relieving factorIndomethacin 432024Callan et al. [47]3 115FRES symptoms (not mentioned exactly the symptoms)NMY‐M—Migraine attackNMSumatriptan and ibuprofen 247FBilateral ear pain and reddeningB/LY‐M—Migraine attackNMMagnesium oxide and ubrogepant 367FRES symptoms (not mentioned exactly the symptoms)NMY‐M—Migraine attackNMOnabotulinum toxin A 442025Ulgen Temel et al. [48]116FRight ear pain (burning sensation) and rednessRY‐M—Migraine attackNMIndomethacin 452025Sandakly et al. [49]114MLeft ear pain (burning sensation) and rednessLN—Stress, rubbing, or touching the ear or heatIce pack to the ear.Adalimumab, ibuprofen, a tricyclic antidepressant (TCA), and a calcium channel blockerAbbreviations: B/L, bilateral; CPH, chronic paroxysmal hemicrania; EPH, episodic paroxysmal hemicrania; F, female; L, left; M, male; N, no; NM, not mentioned; NT, no trigger; R, right; SUNCT, short‐lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing; TAC, trigeminal autonomic cephalalgias; TMJ, temporomandibular joint; Y, yes; Y‐M, Yes‐Migraine. Literature review of case numbers, demographic data, clinic presentation, and characteristics of RES. Abbreviations: B/L, bilateral; CPH, chronic paroxysmal hemicrania; EPH, episodic paroxysmal hemicrania; F, female; L, left; M, male; N, no; NM, not mentioned; NT, no trigger; R, right; SUNCT, short‐lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing; TAC, trigeminal autonomic cephalalgias; TMJ, temporomandibular joint; Y, yes; Y‐M, Yes‐Migraine. Several unusual presentations highlight the heterogeneity of RES. Arjona et al. reported cases of RES following herpes zoster infection attributed to injury of the upper cervical nerve roots and a case triggered by sexual activity in a patient with Chiari Type I malformation, likely due to transient compression of the cerebellar tonsils during exertion [21]. Picco et al. described a pediatric case characterized by burning ear pain associated with subjective tinnitus, transient hearing loss, auditory hallucinations, and vertigo, despite normal ENT and audiological evaluations [27]. Drug‐induced RES has been reported, particularly in association with cytarabine (Ara‐C), an antineoplastic agent used in hematological malignancies such as acute myeloid leukemia [26, 38, 41]. Additionally, Soares et al. described RES following tympanoplasty, hypothesizing that local neuronal injury during surgery triggered symptom onset, supported by rapid symptom relief with topical lidocaine and neuropathic pain medications [44]. No specific or universally effective treatment for RES has been established. Consequently, management strategies are largely guided by the proposed underlying pathophysiological mechanisms [4, 5]. Treatment of primary RES focuses on controlling the associated headache disorder, whereas the management of secondary RES targets the underlying causes. In our case, we started the patient on magnesium supplementation and indomethacin believing that it will target migraine and TACs. Magnesium supplementation is a good option for migraines, and indomethacin is an excellent option for TACs [50, 51]. In our literature review, management strategies demonstrated considerable variability, with therapies largely targeting the presumed underlying mechanisms rather than the syndrome itself. Pharmacological treatment was primarily dominated by neuropathic pain and migraine‐oriented therapies, with gabapentin being the most frequently reported medication, followed by indomethacin and amitriptyline. This observation supports the growing evidence suggesting that neuropathic mechanisms, central sensitization, trigeminovascular activation, and migraine‐related pathways may contribute significantly to RES pathogenesis. Gabapentin was commonly utilized in cases associated with neuropathic pain, cervical pathology, or temporomandibular disorders, whereas indomethacin appeared particularly useful in patients with overlapping TACs and paroxysmal headache syndromes. Similarly, the frequent use of migraine prophylactic therapies including flunarizine, verapamil, topiramate, magnesium supplementation, triptan‐based therapies, and calcitonin gene–related peptide (CGRP)–related agents further reinforces the close association between RES and migraine‐spectrum disorders. Nonpharmacological interventions were similarly heterogeneous and predominantly focused on trigger avoidance and symptomatic relief. Cooling measures, including ice packs, cold environments, and cold‐water application, were frequently reported as effective acute symptomatic strategies, likely due to their vasoconstrictive effects and modulation of neurovascular activation. Furthermore, several cases required more targeted interventions directed toward identifiable secondary causes, including dental appliances for temporomandibular disorders, medication discontinuation for drug‐induced cases, nerve blocks, cervical root interventions, neurovascular decompression procedures, and other surgical approaches for structural pathology. More recently, advanced therapies such as onabotulinum toxin A have emerged as potential options for refractory cases although evidence remains limited to isolated reports. Therapeutic outcomes remain highly variable. Many reported cases require multiple treatment trials with limited benefit, whereas others demonstrate spontaneous resolution. In selected cases of secondary RES, surgical intervention has been necessary as part of definitive management [3, 25]. A limitation in this case is that RES is a rare disease, and the diagnosis is mainly established by excluding other diseases with similar clinical presentations. Furthermore, there is currently no clear evidence supporting racial or ethnic predilection in RES. However, this approach also represents a strength, as comprehensive evaluation and careful exclusion of alternative conditions further strengthened and supported the diagnosis of RES. 4. Conclusion RES is a rare and often underrecognized condition that should be considered in patients presenting with recurrent auricular erythema and burning pain, particularly in those with migraine. This case highlights the importance of a thorough evaluation and exclusion of alternative diagnoses to avoid misdiagnosis and mismanagement. Early recognition of RES may facilitate appropriate treatment, reduce unnecessary interventions, and improve patient outcomes. Author Contributions Zaki Alwatban: manuscript writing literature and review analysis of the reviewed article. Wasan Alharbi: manuscript writing and literature review. Muneera Al Khalifa: manuscript review and analysis result review. Mohammed Al Shehabi: manuscript review and analysis result review. Funding The authors did not receive support from any organization for the submitted work. Disclosure All authors have read and approved the final manuscript. Ethics Statement The study was approved by the Royal Medical Services Ethical and Medical Committee, Bahrain (approval number: RMS‐MH/IRB/2026‐1114). Consent Written informed consent was obtained from the patient. Consent was obtained from patient for publishing the case without disclose any confidential information. Conflicts of Interest The authors declare no conflicts of interest. Patient Perspective The patient experienced ear pain and redness, mainly triggered by migraine attacks, exposure to hot weather, and ear rubbing. The patient was dissatisfied due to multiple clinic visits without any improvement. However, after the diagnosis of RES was established and appropriate management was initiated, the patient was satisfied with the treatment outcomes.